Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Inventory Average (2023 - 2025)

Historic Inventory Average for Iovance Biotherapeutics (IOVA) over the last 3 years, with Q3 2025 value amounting to $50.8 million.

  • Iovance Biotherapeutics' Inventory Average changed N/A to $50.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.8 million, marking a year-over-year change of. This contributed to the annual value of $30.9 million for FY2024, which is N/A changed from last year.
  • Iovance Biotherapeutics' Inventory Average amounted to $50.8 million in Q3 2025.
  • In the past 5 years, Iovance Biotherapeutics' Inventory Average registered a high of $58.5 million during Q1 2025, and its lowest value of $9.5 million during Q3 2023.
  • Moreover, its 3-year median value for Inventory Average was $32.4 million (2024), whereas its average is $33.4 million.
  • Within the past 5 years, the most significant YoY rise in Iovance Biotherapeutics' Inventory Average was 31825.36% (2025), while the steepest drop was 31825.36% (2025).
  • Iovance Biotherapeutics' Inventory Average (Quarter) stood at $9.8 million in 2023, then soared by 43.04% to $14.0 million in 2024, then surged by 262.8% to $50.8 million in 2025.
  • Its Inventory Average stands at $50.8 million for Q3 2025, versus $57.7 million for Q2 2025 and $58.5 million for Q1 2025.